last updated: 2 months ago

last updated: 2 months ago

Human Longevity, Inc. logo

Human Longevity, Inc.

Human Longevity, Inc.

Human Longevity, Inc.

Most serious disease is preventable when you find it early. Live 100+ Healthy Years, Achieve 100% of Your Potential.

Most serious disease is preventable when you find it early. Live 100+ Healthy Years, Achieve 100% of Your Potential.

Biotechnology Research

Biotechnology Research

South San Francisco

South San Francisco

US

US

51–200 employees

51–200 employees

January 2013

January 2013

Overview

Overview

Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine.

Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.

Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine.

Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.

Key personnel profiles

Key personnel profiles

Key personnelS

Wei-Wu He, Ph.D. (He/him)

Chairman and CEO, Human Longevity, Inc. | Building AI-Powered Precision Longevity Medicine for Everyone | Genomics • Early Cancer Detection • Healthspan

view profile

Hiring Trend

Hiring Trend

TOTAL hires

TOTAL hires

8

8

APR'26MAY'26JUN'26JUL'26AUG'26
APR'26MAY'26JUN'26JUL'26AUG'26

Employee Growth

Employee Growth

TOTAL EMPLOYEES

TOTAL EMPLOYEES

85

85

6m GROWTH

6m GROWTH

5%

5%

1y GROWTH

1y GROWTH

16%

16%

NOV'25DEC'25JAN'26FEB'26MAR'26APR'26MAY'26JUN'26JUL'26AUG'26SEP'26OCT'26
NOV'25DEC'25JAN'26FEB'26MAR'26APR'26MAY'26JUN'26JUL'26AUG'26SEP'26OCT'26

Employee Distribution & Department Growth

Employee Distribution & Department Growth

TOTAL EMPLOYEES

TOTAL EMPLOYEES

85

85

6m GROWTH

6m GROWTH

1y GROWTH

1y GROWTH

Department distribution

Department distribution

Department distribution

DEPARTMENT

6m GROWTH

1y GROWTH

Healthcare Services

Healthcare Services

Healthcare Services

0%

0%

0%

0%

0%

0%

Business Development

Business Development

Business Development

6%

6%

6%

31%

31%

31%

Operations

Operations

Operations

20%

20%

20%

50%

50%

50%

Information Technology

Information Technology

Information Technology

0%

0%

0%

0%

0%

0%

Administrative

Administrative

Administrative

33%

33%

33%

33%

33%

33%

Web Engagement

pages per visit

pages per visit

1.8

1.8

monthly visits

monthly visits

32,738

32,738

JUL'26AUG'26SEP'26
JUL'26AUG'26SEP'26

Web Traffic by Country

Web Traffic by Country

United States

87.2%

United States

87.2%

United Kingdom

4.7%

United Kingdom

4.7%

India

4.2%

India

4.2%

Germany

3.8%

Germany

3.8%

Web Traffic Sources

Web Traffic Sources

monthly visits

32,738

Direct

16%

Direct

16%

Search

49.5%

Search

49.5%

Social

0%

Social

0%

Referrals

0%

Referrals

0%

AI

4.1%

AI

4.1%

funding round

funding round

12

total funding raised

total funding raised

$1.1B

last round type

last round type

Series B

last round amount

last round amount

$39.8M

announced on

announced on

$39.8M

funding round

12

total funding raised

$1.1B

last round type

Series B

last round amount

$39.8M

announced on

$39.8M

lead investors

lead investors

lead investors

TVM Capital Healthcare, Panacea Venture, Emerging Technology Partners, BroadOak Capital Partners, G Vision Capital, Shin Ryoku Trust

TVM Capital Healthcare, Panacea Venture, Emerging Technology Partners, BroadOak Capital Partners, G Vision Capital, Shin Ryoku Trust

Recent News & Articles

Recent News & Articles

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.